InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Bradner James E.. Officer active across 1 company, notably AMGEN INC. Aggregated, 5 filings have been logged. Activity tracked since 9 February 2024. The latest transaction was disclosed on 9 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Bradner James E. is a declarant linked to AMGEN INC, where he is EVP, Research and Development. Across 5 filings in total, the 5 sampled filings run from 2024-02-12 to 2026-02-10 and the modal transaction nature is Attribution, with buy and sell amounts of EUR 0 in this recent sample.